Both are at-home plasma pens. Both use the same basic fibroblast technology. But they are not targeting the same buyer, and that distinction matters more than most comparison articles will tell you. This page is the honest side-by-side.
For a full roundup of every at-home plasma pen on the market, see our 2026 plasma pen buyer's guide. This page is the head-to-head.
Key takeaways
The moles question is where the two brands part ways. Here is what that means for you.
- Both use plasma fibroblast technology at home.
- The Ocura Plasma Pen targets skin tags, cherry angiomas, milia, sebaceous hyperplasia, age spots, fine lines, and more.
- NuzzyPen markets toward mole removal. OcuraLife does not, by policy, for safety reasons.
- If your concern is skin tags or cherry angiomas, the Ocura Pen was built for that use case.
- If you have a mole, see a dermatologist before any at-home treatment.
What the Ocura Plasma Pen actually does
The OcuraLife Plasma Pen delivers plasma energy through a precision tip directly to a blemish. The energy carbonizes the surface tissue at the cellular level without contacting the surrounding skin. Each treatment takes about 5 minutes per spot.
The conditions it is designed for: skin tags, cherry angiomas, milia, sebaceous hyperplasia, age spots, fine lines, sagging eyelids, acne scars, stretch marks, and sun damage. Nine adjustable power settings let you match the intensity to the size and depth of the blemish you are treating. More on that device mechanism at MedlinePlus.
After treatment, a small protective scab forms and falls off naturally between Day 3 and Day 7. By Week 2 to Week 3, the treated area reveals smooth, clear skin. Over 28,000 customers have used this device. The rating sits at 4.87 out of 5 across 433 reviews.
What it does not target: moles. More on that below.
If you are treating skin tags specifically, see our full skin tags guide to understand the mechanism in depth before starting.
Side by side: how the two devices compare
Read this before making a decision.
The device technology is comparable. The meaningful difference is in what each brand chooses to market the device for, and what that says about how the brand approaches safety.
The moles question: where each brand stands
NuzzyPen markets toward moles. OcuraLife does not.
That is not a capability statement. It is a safety decision.
A mole can be benign. It can also be melanoma or a precancerous lesion. A dermatologist can examine a mole in person and make that determination. A home-use device cannot. The American Academy of Dermatology recommends that any mole be examined by a dermatologist before at-home removal is considered. Read more about that guidance at aad.org.
OcuraLife's policy reflects that recommendation. If you have a skin growth and are not certain whether it is a mole or a benign blemish like a sebaceous hyperplasia or a skin tag, see a dermatologist first. That step is free to ask about, and it protects you. For general information about skin conditions, MedlinePlus and Mayo Clinic are reliable starting points.
Once a dermatologist confirms a growth is benign, at-home plasma pen treatment is a valid option for many blemish types.
If you are not sure, see a dermatologist first
Any growth that could be a mole, that bleeds without contact, that has changed shape or color over weeks, or that has visible blood vessels on the surface needs a dermatologist's eye, not a device. The plasma pen is for confirmed benign blemishes only.
Why OcuraLife customers choose the Ocura Pen
The 28,000+ customer base breaks down to a specific use case: women 35 to 55 who want a clinic-quality result for a skin tag, cherry angioma, milia pocket, or age spot cluster without a $200+ dermatology bill per blemish.
The OcuraLife Plasma Pen was built for that use case. Nine power settings mean you can treat a tiny milia at low power and a deeper sebaceous hyperplasia nodule at higher power without switching devices. The 5-minute treatment window fits into a bathroom routine. The 90-day money-back guarantee means the risk is on us if it does not work for you.
The device that wins for you is the one designed for what you are actually treating. If your condition is skin tags, cherry angiomas, milia, age spots, or any of the other conditions on our list, the OcuraLife Plasma Pen was built for it.
Related comparisons
- Ocura Plasma Pen vs Dermavel: The Honest 2026 Comparison
- Ocura Plasma Pen vs Neuderma: The Honest 2026 Comparison
- Plasma Pen vs Freeze Kits: Which At-Home Removal Actually Works
FAQ
Frequently asked questions
Quick answers
Common questions from buyers comparing the Ocura Plasma Pen and NuzzyPen before purchase.
↓ Tap each question to reveal the answer.
The bottom line
The Ocura Plasma Pen and NuzzyPen use the same underlying fibroblast technology. The deciding factor is what you are actually treating. For skin tags, cherry angiomas, milia, age spots, and the other confirmed benign conditions on the OcuraLife target list, the Ocura Pen was purpose-built for that buyer. For the moles question, both brands ultimately agree: a dermatologist should look at any mole before at-home removal is attempted. OcuraLife just makes that the policy rather than the fine print.
Related comparisons in this series
- The Best At-Home Plasma Pen in 2026: An Honest Roundup (the full comparison pillar)
- Ocura Plasma Pen vs Dermavel: The Honest 2026 Comparison
- Ocura Plasma Pen vs Neuderma: The Honest 2026 Comparison
- Plasma Pen vs Freeze Kits: Which At-Home Removal Actually Works
28,000+
Customers served
90 days
Risk-free trial
At home
No clinic, no appointment
For confirmed benign blemishes only
The OcuraLife Plasma Pen is built for this
Delivers focused plasma energy at the surface of the blemish. Nine adjustable power settings, single-use sterile tips. A small scab forms, falls off on its own, and the skin renews. For confirmed skin tags, cherry angiomas, milia, age spots, and more, backed by a 90-day money-back guarantee and 28,000+ customers.
See the Plasma Pen
